Primary fibroblasts from asthma patients, but not fibroblasts isolated from CF or COPD patients, expressed significantly increased levels of αSMA and BiP compared to controls, which were decreased by treatment with 4μ8C (Fig 6E and F). The gene discussed is ACTA1; the disease is asthma.